Scholay

学术搜索 · AI 审稿 · LaTeX 协作

A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer

作者:Jennifer J. Knox, Mairéad G. McNamara, I. Bazin, Do‐Youn Oh, O. Zubkov, В. В. Бредер, Li‐Yuan Bai, Alan Christie, Lipika Goyal, David Cosgrove, Christoph Springfeld, Katrin Marie Sjoquist, Joon Oh Park, Helena Verdaguer, Chiara Braconi, Paul J. Ross, Aimery de Gramont, Rachna T. Shroff, John Zalcberg, Daniel H. Palmer, Jonathan R. Smith, Elisabeth Oelmann, Theresa Bruce, Juan W. Valle · 发表于:Journal of Hepatology · 年份:2025 · DOI:10.1016/j.jhep.2025.01.040 · 被引用次数:13 · 研究领域:Cholangiocarcinoma and Gallbladder Cancer Studies、Gallbladder and Bile Duct Disorders、Pancreatic and Hepatic Oncology Research